XOMA Royalty Corp (XOMA) — Inside-Filings

Sentiment-Signal

29,3

Bearisch

Composite Score (0–100)

Insider (25%)

Keine Insider-Käufe

Institutionell (22,5%)

Keine neuen Positionen

Aktivist (12,5%)

Kein 13D/13G

Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

XOMA Royalty Corp. operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Unternehmen & Branche

Name	XOMA Royalty Corp
Ticker	XOMA
CIK	0000791908
Boerse	US
Sektor	Healthcare
Industrie	Biotechnology
SIC	2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP	–
ISIN	–
Typ	Common Stock
Marktkapitalisierung	495,0 Mio. USD
Beta	0,68
Dividendenrendite	2,16 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

Periode	Filing	Umsatz	Nettoergebnis	EPS	Aktiva	Eigenkapital
2025-12-31	10-K	52,149,000	31,712,000	1.46	272,698,000	83,941,000
2025-09-30	10-Q	9,351,000	14,051,000	0.70	263,151,000	87,938,000
2025-06-30	10-Q	13,129,000	9,191,000	0.44	223,456,000	72,435,000
2025-03-31	10-Q	15,912,000	2,367,000	0.06	212,750,000	84,629,000
2024-12-31	10-K	28,487,000	-13,821,000	-1.65	221,277,000	61,902,000
2024-09-30	10-Q	7,197,000	-17,243,000	-1.59	223,340,000	84,809,000
2024-06-30	10-Q	11,086,000	15,985,000	0.84	243,280,000	99,993,000
2024-03-31	10-Q	1,490,000	-8,595,000	-0.86	219,420,000	82,341,000
2023-12-31	10-K	4,758,000	-40,831,000	-4.04	234,301,000	88,721,000
2023-09-30	10-Q	830,000	-5,509,000	-0.60	124,094,000	105,964,000
2023-06-30	10-Q	1,658,000	-5,400,000	-0.59	125,661,000	110,124,000
2023-03-31	10-Q	437,000	-9,813,000	-0.98	133,664,000	114,526,000
2022-12-31	10-K	6,027,000	-17,104,000	-1.98	140,382,000	124,014,000
2022-09-30	10-Q	451,000	-4,178,000	-0.48	146,131,000	130,325,000
2022-06-30	10-Q	983,000	-4,670,000	-0.53	154,222,000	134,956,000
2022-03-31	10-Q	3,107,000	-2,280,000	-0.32	159,160,000	139,924,000
2021-12-31	10-K	38,160,000	15,798,000	0.65	166,562,000	141,876,000
2021-09-30	10-Q	940,000	-4,436,000	-0.51	130,503,000	111,584,000
2021-06-30	10-Q	901,000	-2,237,000	-0.31	135,752,000	116,578,000
2021-03-31	10-Q	375,000	-7,373,000	-0.70	119,893,000	81,720,000

Fondsaktivität (Vorquartalsvergleich)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

Datum	Insider	Rolle	Typ	Stückzahl	Kurs	Wert (USD)	Δ
2025-12-04	Hughes Owen	Director, Officer, Chief Executive Officer	Open Market Purchase	100,000	25.05	2,505,000.00	+158,0%
2025-09-22	BURNS THOMAS M.	Officer, SVP, Finance & CFO	Open Market Sale	-15	36.81	-552.15	0,0%
2025-09-22	BURNS THOMAS M.	Officer, SVP, Finance & CFO	Open Market Sale	-4,300	35.98	-154,714.00	-9,8%
2025-09-22	BURNS THOMAS M.	Officer, SVP, Finance & CFO	Open Market Sale	-15	36.93	-553.95	0,0%
2025-06-30	Sitko Bradley	Officer, Chief Investment Officer	Open Market Purchase	2,000	25.39	50,780.00	+3,2%
2025-05-20	BURNS THOMAS M.	Officer, SVP, Finance & CFO	Open Market Sale	-10,482	25.38	-266,033.16	-16,8%
2025-05-20	Hughes Owen	Director, Officer, Chief Executive Officer	Open Market Sale	-25,637	25.38	-650,667.06	-41,0%
2025-05-16	BVF PARTNERS L P/IL	10% Owner	Open Market Sale	-127,407	27.10	-3,452,729.70	-217,7%
2025-05-16	BVF PARTNERS L P/IL	10% Owner	Open Market Sale	-265,316	27.10	-7,190,063.60	-453,4%

Top-Fondshalter

Keine Fondsdaten zu dieser Aktie vorhanden.